BBS10 and Bardet-Biedl syndrome: This mainly applied to male BBS patients (89%, 8/9), patients with a pathogenic variant in the BBS10 gene (56%, 5/9), and those with elevated ATI (0.71 dB/cm/Mhz) and SWE levels (6.8 kPa).